CoChat

Aspirin use is associated with lower indices of liver fibrosis among adults in the United States

Jiang, Z. Gordon, Feldbrügge, L., Tapper, E. B., Popov, Y., Ghaziani, T., Afdhal, N., Robson, S. C., Mukamal, K. J. · 2016 · Alimentary Pharmacology & Therapeutics
Cited by 107

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Background: Recent animal studies have shown that platelets directly activate hepatic stellate cells to promote liver fibrosis, whereas anti‐platelet agents decrease liver fibrosis. It is unknown whether platelet inhibition by aspirin prevents liver fibrosis in humans. Aim: To examine the association between aspirin use and liver fibrosis among adults with suspected chronic liver disease. Methods: We conducted a cross‐sectional analysis using data from the National Health and Nutrition Examination Survey III. We identified 1856 individuals with suspected chronic liver disease (CLD). The degree of liver fibrosis was determined using four validated fibrosis indices and a composite index. Results: The use of aspirin was associated with a significantly lower composite liver fibrosis index calculated from FIB 4, APRI, Forns and NFS [0.24 standard deviation (s.d.) units lower; 95% CI −0.42 to −0.06, P = 0.009]. The association of aspirin with lower fibrosis scores was significantly larger among those with suspected CLD compared to those without (−0.23 vs. −0.03 s.d. units; P interaction = 0.05). The negative association between aspirin use and lower fibrosis index was consistent across all four fibrosis indices (P = 0.002–0.08) in individuals with chronic viral hepatitis, suspected alcoholic liver disease and NASH. In comparison, no negative associations with liver fibrosis were seen with ibuprofen in parallel analyses. Conclusions: The use of aspirin was associated with significantly lower indices of liver fibrosis among US adults with suspected chronic liver diseases. Aspirin and other anti‐platelet drugs warrant further investigation for the prevention and treatment of liver fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13515

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 107

Metadata

Authors
Jiang, Z. G., Feldbrügge, L., Tapper, E. B., Popov, Y., Ghaziani, T., Afdhal, N., Robson, S. C., & Mukamal, K. J.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2016-01-07
Volume
43
Issue
6
Pages
734-743
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2229541017
Cited by
107
References
6
FWCI
6.00
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. https://app.cochat.ai/papers/10.1111/apt.13515
The paper
Jiang, Z. G., Feldbrügge, L., Tapper, E. B., Popov, Y., Ghaziani, T., Afdhal, N., Robson, S. C., & Mukamal, K. J. (2016). Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.13515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.